Arbutus Biopharma CorporationABUSNASDAQ
LOADING
|||
ROE: Returns Declining
Strong compound growth.
Left:
||||
Return on equity
Latest
-71.81%
Near historical average
Average (9y)
-78.52%
Historical baseline
Range
High:-11.16%
Low:-211.32%
CAGR
+23.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -71.81% | -4.5% |
| 2023 | -68.71% | -35.4% |
| 2022 | -50.75% | -12.8% |
| 2021 | -45.00% | +28.0% |
| 2020 | -62.52% | +70.4% |
| 2019 | -211.32% | -641.0% |
| 2018 | -28.52% | +38.3% |
| 2017 | -46.25% | +75.6% |
| 2016 | -189.21% | -1595.4% |
| 2015 | -11.16% | - |